GLP-1单克隆抗体

英文名称 GLP-1(1G9)
中文名称 GLP-1单克隆抗体
别 名 GCG; GLP 1; glucagon; Glucagon like peptide 1; GRPP; GLP-1(7-36); GLP-1(7-37); Oxyntomodulin; OXM; OXY; GLUC_HUMAN.
GLP-1单克隆抗体
说 明 书 0.1ml 0.2ml
研究领域 肿瘤 心血管 免疫学 神经生物学 信号转导 生长因子和激素 糖尿病 内分泌病 新陈代谢
抗体来源 Mouse
克隆类型 Monoclonal
克 隆 号 1G9
交叉反应 Human, Mouse, Rat,
产品应用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 （石蜡切片需做抗原修复）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
分 子 量 21kDa
细胞定位 分泌型蛋白
性 状 Lyophilized or Liquid
浓 度 1mg/1ml
免 疫 原 KLH conjugated synthetic peptide derived from human GLP-1
亚 型 IgG
纯化方法 affinity purified by Protein A
储 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide
保存条件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
GLP-1单克隆抗体
产品介绍 background:
Glucagon plays a key role in glucose metabolism and homeostasis. Regulates blood glucose by increasing gluconeogenesis and decreasing glycolysis. A counterregulatory hormone of insulin, raises plasma glucose levels in response to insulin-induced hypoglycemia. GLP-1 is a potent stimulator of glucose-dependent insulin release. Play important roles on gastric motility and the suppression of plasma glucagon levels. May be involved in thesuppression of satiety and stimulation of glucose disposal in peripheral tissues, independent of the actions of insulin. Have growth-promoting activities on intestinal epithelium. May also regulate the hypothalamic pituitary axis (HPA) via effects on LH, TSH, CRH, oxytocin, and vasopressin. Belongs to the glucagon family.

Function:
Glucagon plays a key role in glucose metabolism and homeostasis. Regulates blood glucose by increasing gluconeogenesis and decreasing glycolysis. A counterregulatory hormone of insulin, raises plasma glucose levels in response to insulin-induced hypoglycemia. Plays an important role in initiating and maintaining hyperglycemic conditions in diabetes.
GLP-1 is a potent stimulator of glucose-dependent insulin release. Play important roles on gastric motility and the suppression of plasma glucagon levels. May be involved in the suppression of satiety and stimulation of glucose disposal in peripheral tissues, independent of the actions of insulin. Have growth-promoting activities on intestinal epithelium. May also regulate the hypothalamic pituitary axis (HPA) via effects on LH, TSH, CRH, oxytocin, and vasopressin secretion. Increases islet mass through stimulation of islet neogenesis and pancreatic beta cell proliferation. Inhibits beta cell apoptosis.
GLP-2 stimulates intestinal growth and up-regulates villus height in the small intestine, concomitant with increased crypt cell proliferation and decreased enterocyte apoptosis. The gastrointestinal tract, from the stomach to the colon is the principal target for GLP-2 action. Plays a key role in nutrient homeostasis, enhancing nutrient assimilation through enhanced gastrointestinal function, as well as increasing nutrient disposal. Stimulates intestinal glucose transport and decreases mucosal permeability.
Oxyntomodulin significantly reduces food intake. Inhibits gastric emptying in humans. Suppression of gastric emptying may lead to increased gastric distension, which may contribute to satiety by causing a sensation of fullness.
Glicentin may modulate gastric acid secretion and the gastro-pyloro-duodenal activity. May play an important role in intestinal mucosal growth in the early period of life

Subcellular Location:
Secreted.

Tissue Specificity:
Glucagon is secreted in the A cells of the islets of Langerhans. GLP-1, GLP-2, oxyntomodulin and glicentin are secreted from enteroendocrine cells throughout the gastrointestinal tract. GLP1 and GLP2 are also secreted in selected neurons in the brain.

Post-translational modifications:
Proglucagon is post-translationally processed in a tissue-specific manner in pancreatic A cells and intestinal L cells. In pancreatic A cells, the major bioactive hormone is glucagon cleaved by PCSK2/PC2. In the intestinal L cells PCSK1/PC1 liberates GLP-1, GLP-2, glicentin and oxyntomodulin. GLP-1 is further N-terminally truncated by post-translational processing in the intestinal L cells resulting in GLP-1(7-37) GLP-1-(7-36)amide. The C-terminal amidation is neither important for the metabolism of GLP-1 nor for its effects on the endocrine pancreas.

Similarity:
Belongs to the glucagon family.
GLP-1单克隆抗体
xy-4171R Angiomotin血管动蛋白抗体
xy-6136R Adenovirus 5 E1A腺病毒早期E1A蛋白抗体
xy-5170R phospho-ATF2 (Ser44)磷酸化活化复制因子2抗体
xy-5171R phospho-ATF2 (Ser94)磷酸化活化复制因子2抗体
xy-5213R phospho-ATXN1(Thr236)磷酸化失调症蛋白1抗体
xy-9295R ANKRD17锚蛋白重复结构域蛋白17抗体
xy-6509R ALDH1A1胞质乙醛脱氢酶1抗体
xy-6162R ARL3ADP核糖基化样因子ARL3抗体
xy-6505R 15 Lipoxygenase 1花生四烯酸15脂氧合酶1抗体
xy-6515R ABC2乳腺癌增强蛋白2抗体
xy-6512R Alpha 1 microglobulinα1微球蛋白抗体
xy-4651R Alpha B Crystallinα晶状体球蛋白B/αB-crystallin抗体
xy-5900R ADORA2B腺苷A2b受体/神经生长因子1受体抗体
xy-6251R ARK5AMPK的相关蛋白激酶5抗体
xy-5927R ANP32C致瘤磷蛋白32相关蛋白1抗体
xy-6654R Adenosine deaminase腺苷脱氨酶抗体
xy-9130R ASB4含锚蛋白重复序列-细胞因子信号抑制物盒蛋白家族4抗体
xy-11504R ATRNL1ATRNL1蛋白抗体
xy-10081R AFP4aAFP4a蛋白抗体
xy-11627R APBB2铁蛋白Fe65样蛋白1抗体
xy-11637R APBB3铁蛋白Fe65样蛋白2抗体
xy-11639R APPBP2β淀粉样蛋白前体蛋白结合蛋白2抗体
xy-11640R Aph-1b早老素稳定因子样蛋白/γ分泌酶组件蛋白APH1抗体
xy-10133R phospho-AKT1 (Tyr474)磷酸化蛋白激酶AKT1抗体
xy-10134R phospho-AKT1 (Ser473 + Tyr474)磷酸化蛋白激酶AKT1抗体
xy-11866R ASH1LASH1L蛋白抗体
xy-12040R ADRA2Cα2C-AR肾上腺素能受体抗体
xy-12977R AZI1中心体蛋白AZI1抗体
xy-7857R ALPK3α蛋白激酶3抗体（心肌）
xy-7856R ALOXE3表皮型脂氧合酶3抗体（鱼鳞病相关蛋白）
xy-7926R ANKRD28锚蛋白重复域28抗体
xy-7886R AFF4淋巴细胞相关AF4样蛋白抗体
xy-7962R ANKRD12锚蛋白重复结构域蛋白12抗体
xy-7963R ANKRD13A锚蛋白重复结构域蛋白13A抗体
xy-7964R ANKRD9锚蛋白重复结构域蛋白9抗体
xy-7966R ANKS1A锚蛋白重复及SAM结构域蛋白1A抗体